Skip to main content

‘It made us look bad’: Pharma CEOs clash over Allergan patent move

Allergan Chief Executive Brent Saunders stood behind the company’s controversial deal with an American Indian tribe on Thursday, despite an investor backlash and a judge ruling against it last month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.